Regulation of Human Megakaryocytopoiesis

  • Ronald Hoffman
  • Michael W. Long
Chapter
Part of the Developments in Oncology book series (DION, volume 80)

Abstract

Megakaryocytopoiesis is a complex biological process involving a series of cellular events that begins with the pluripotent hematopoietic stem cell and ultimately results in the biogenesis of platelets1. A hierarchy of MK progenitor cells, the progeny of which eventually proliferate and mature into MKs, has been defined1–3.

Keywords

Human Megakaryocyte Megakaryocyte Progenitor Fetal Bone Marrow Megakaryocyte Progenitor Cell Demarcation Membrane System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hoffman R. Regulation of megakaryocytopoiesis. Blood 74:1196–1212, 1989PubMedGoogle Scholar
  2. 2.
    Long MW. Population heterogeneity among cells of the MK lineage. Stem Cells 11:33–40, 1993PubMedGoogle Scholar
  3. 3.
    Bruno E, Hoffman R. Human megakaryocyte progenitor cells. Sem Hematol 35:183–192, 1998Google Scholar
  4. 4.
    Gordon MS, Hoffman R. Growth factors affecting human thrombocytopoiesis: Potential agents for the treatment of thrombocytopenia. Blood 80:302–307, 1992PubMedGoogle Scholar
  5. 5.
    Long MW, Dixit V. Thrombospondin functions as a cytoadhesion molecule for human hematopoietic progenitor cells. Blood 75:311–2319, 1990Google Scholar
  6. 6.
    Long MW, Briddell RA, Walter AU, et al. Human hematopoietic stem cells adherence to cytokines and matrix molecules. J Clin Invest 90:251–255, 1992PubMedGoogle Scholar
  7. 7.
    Bruno E, Luikart SD, Long MW, et al. Marrow-derived heparan/sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines. Exp Hemat 23:1212–1217, 1995PubMedGoogle Scholar
  8. 8.
    Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest 48:963–974, 1969PubMedGoogle Scholar
  9. 9.
    Long MW: Blood cell cytoadhesion molecules. Exp Hematol 20:288–301, 1992PubMedGoogle Scholar
  10. 10.
    Leven RM, Yee T. Collagenase production by guinea pig megakaryocytes in vitro. Exp Hematol 18:743–747, 1990PubMedGoogle Scholar
  11. 11.
    Eldor A. Fuks Z, Levine RF, Vlodavsky I. Measurement of platelet and megakaryocyte interaction with the subendothelial extracellular matrix. Methods Enzymol 169:76–9, 1989PubMedGoogle Scholar
  12. 12.
    Hansen M, Pedersen NT. Circulating megakaryocytes in patients with pulmonary inflammation and in patients subjected to cholecystectomy. Scand J Haematol 23:211–216, 1979PubMedGoogle Scholar
  13. 13.
    Zauli G, Vitale L, Brunelli MA, Bagnara GP. Prevalence of the primitive megakaryocyte progenitors (BFU-meg) in adult human peripheral blood. Exp. Hematol 20:850–854, 1992PubMedGoogle Scholar
  14. 14.
    Grouls V, Helpap B. Megakaryocytopoiesis in the spleen of growing rats. Am J Anat 157:429–432, 1980PubMedGoogle Scholar
  15. 15.
    Kaufman KM, Ario R, Pollack S, et al. Origin of pulmonary megakaryocytes. Blood 25:767, 1965PubMedGoogle Scholar
  16. 16.
    Long MW, Gragowski LL, Heffher CH, et al. Phorbol esters stimulate the development of an early murine progenitor cell. The burst forming unit-megakaryocyte. J Clin Invest 1985;76:431–438PubMedGoogle Scholar
  17. 17.
    Briddell RA, Brandt JE, Straneva JE, et al. Characterization of the human burst forming unit-megakaryocyte. Blood 74:145–151, 1989PubMedGoogle Scholar
  18. 18.
    Jackson H, Williams N, Bertoncello I, et al. Classes of primitive murine megakaryocyte progenitor cells. Exp Hematol 22:954–958, 1994PubMedGoogle Scholar
  19. 19.
    Bruno E, Murray LJ, DiGusto R, et al. Detection of a primitive megakaryocyte progenitor cell in human fetal bone marrow. Exp Hematol 24:552–558, 1996PubMedGoogle Scholar
  20. 20.
    Murray LJ, Bruno E, Yeo EL, et al. CDwl09 antibody 8A3 identifies a minor subset of CD34+ fetal bone marrow cells that includes multilineage and megakaryocyte progenitor cells as well as hematopoietic stem cells. Blood 84:237a, 1994Google Scholar
  21. 21.
    Briddell RA, Hoffman R. Cytokine regulation of the human burst forming unit-megakaryocyte. Blood 76:516–522, 1990PubMedGoogle Scholar
  22. 22.
    Hunt P: A bipotential megakaryocyte/erythrocyte progenitor cell. The link between erythropoiesis and megakaryopoiesis becomes stronger. J Lab Med 125:303–304, 1995Google Scholar
  23. 23.
    Debili N, Coulombel L, Croisille L, et al. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood 88:1284–1296, 1996PubMedGoogle Scholar
  24. 24.
    Telamula M, Katahira J, Hoshino S, et al. Effect of recombinant growth factors on human megakaryocyte colony formation in serum-free cultures. Exp Hematol 17:1011–1016, 1989Google Scholar
  25. 25.
    Bruno E, Miller ME, Hoffman R. Interacting cytokines regulate in vitro human megakaryocytopoiesis. Blood 73:67–77, 1989Google Scholar
  26. 26.
    Debili N, Massè JM, Katz A, et al. Effects of the recombinant hematopoietic growth factors interleukin 3, interleukin 6, stem cell factor, and leukemia inhibitory factor on the megakaryocyte differentiation of CD34+ cells. Blood 82:84–95, 1993PubMedGoogle Scholar
  27. 27.
    McNiece IK, Langley KE, Zsebo KM, et al. Recombinant stem cell factor synergizes with GM-CSF, G-CSF, IL-3 and EPO to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 19:226–231, 1991PubMedGoogle Scholar
  28. 27.
    Murray LJ, Mandich D, Bruno E, et al. Fetal bone marrow CD34+ CD41+ cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells. Exp Hematol 24:236–245, 1996PubMedGoogle Scholar
  29. 28.
    Papayannopoulou T, Brice M, Fairer D, et al. Insights into the cellular mechanisms of erythropoietin-TPO synergy. Exp Hematol 24:660–699, 1996PubMedGoogle Scholar
  30. 29.
    Debili N, Issaad C, Massè JM, et al. Expression of CD34 and platelet glycoproteins during human megakaryocyte differentiation. Blood 80:3022–3035, 1992PubMedGoogle Scholar
  31. 30.
    Louache F, Debili N, Marandin A, et al. Expression of CD4 by human hematopoietic progenitors. Blood 84:3344–3355, 1994PubMedGoogle Scholar
  32. 31.
    Dolzhansvy A, Basch RS, Karpatkin S. Development of human megakaryocytes: I. Hematopoietic progenitors (CD34+ bone marrow cells) are enriched with megakaryocytes expressing CD4. Blood 87:1353–1360, 1996Google Scholar
  33. 32.
    Zauli G, Furlini G, Vitale M, et al. A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high affinity receptor for human immunodeficiency Virus-Type 1. Blood 84:1896–1905, 1994PubMedGoogle Scholar
  34. 33.
    Long MW, Williams N, McDonald TP. Immature megakaryocytes in the mouse: in vitro relationship to megakaryocyte progenitor cells and mature megakaryocytes. J Cell Physiol 112:339–344, 1982PubMedGoogle Scholar
  35. 34.
    Jackson CW. Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood 42:413–421, 1973PubMedGoogle Scholar
  36. 35.
    Rabellino EM, Levene RB, Leung LLK, Nachman RL. Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes. J Exp Med 154:88–100, 1981PubMedGoogle Scholar
  37. 36.
    Rabellino EM, Nachman RL, Williams N, et al: Human megakaryocytes. I. Characterization of the membrane and cytoplasmic components of isolated marrow megakaryocytes. J Exp Med 149:1273–1287, 1979PubMedGoogle Scholar
  38. 37.
    Vainchenker W, Guichard J, Deschamps J F, et al: Megakaryocyte cultures in the chronic phase and in the blast crisis of chronic myeloid leukaemia: Studies on the differentiation of the megakaryocyte progenitors and on the maturation of megakaryocytes in vitro. Br J Haematol 51:131146, 1982Google Scholar
  39. 38.
    Long MW, Williams N, Ebbe S. Immature megakaryocytes in the mouse: Physical characteristics, cell cycle status, and in vitro responsiveness to thrombopoietic stimulatory factor. Blood 59:569–575, 1982PubMedGoogle Scholar
  40. 39.
    Long MW, Henry RL: Thrombocytosis-induced suppression of small acetylcholinesterase positive cells in bone marrow of rats. Blood 54:1339, 1979Google Scholar
  41. 40.
    Long MW: Megakaryocyte differentiation events. Sem Hematol 35:192–199, 1998Google Scholar
  42. 41.
    Long MW, Hutchinson RJ, Gragowski LL, Heffner CH, Emerson SG. Synergistic regulation of human megakaryocyte development. J Clin Invest 82:1779–1786, 1998Google Scholar
  43. 42.
    Williams N, Jackson H. Regulation of the proliferation of murine megakaryocyte progenitor cells by cell cycle. Blood 52:163–170, 1978PubMedGoogle Scholar
  44. 43.
    Hoffman R, Yang HH, Bruno E, Straneva JE. Purification and partial characterization of a megakaryocyte colony-stimulating factor from human plasma. J Clin Invest 75:1174–1182, 1985PubMedGoogle Scholar
  45. 44.
    Quesenberry PJ, McGrath HE, Williams ME, et al. Multifactor stimulation of megkaryocytopoiesis: effects of interleukin 6. Exp Hematol 19:35–41, 1991PubMedGoogle Scholar
  46. 45.
    Long MW, Heffner CH, Gragowski LL. Cholera toxin and phorbol diesters synergistically modulate murine hematopoietic progenitor cell proliferation. Exp Hematol 1988;16:195–200PubMedGoogle Scholar
  47. 46.
    Yoshimasa T, Sibley DR, Bouvier M, et al. Cross-talk between cellular signalling pathways suggested by phorbol-ester-induced adenylate cyclase phosphorylation. Nature 327:67–70, 1987PubMedGoogle Scholar
  48. 47.
    Emerson SG, Yang YC, Clark SC, Long MW. Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct activities. J Clin Invest 82:12821287, 1988Google Scholar
  49. 48.
    Lindemann A, Ganser A, Herrmann F, et al. Biologic effects of recombinant human interleukin-3 in vivo. J Clin Oncol 9:2120–2127, 1991PubMedGoogle Scholar
  50. 49.
    Ishibashi T, Burstein SA. Interleukin 3 promotes the differentiation of isolated single megakaryocytes. Blood 67:1512–1514, 1986PubMedGoogle Scholar
  51. 50.
    Kimura H, Ishibashi T, Uchida T, et al. Interleukin 6 is a differentiation factor for human megakaryocytes n vitro. Eur J Immunol 20:1927–1931, 1992Google Scholar
  52. 51.
    Bruno E, Briddell RA, Cooper RJ, Hoffman R. Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells. Exp Hematol 19:378–381, 1991PubMedGoogle Scholar
  53. 52.
    McNiece IK, McGrath HE, Quesenberry PJ. Granulocyte colony-stimulating factor augments in vitro megakaryocyte colony formation by interleukin-3. Exp. Hematol 16:807–810, 1988Google Scholar
  54. 53.
    Debili N, Hegyi E, Navarro S, et al. In vitro effects of hematopoietic growth factors on the proliferation, endoreplication, and maturation of human megakaryocytes. Blood 77:2326–2338, 1997Google Scholar
  55. 54.
    Du XX, Williams PA: Interleukin 11. A multifunctional growth factor derived from the hematopoietic microenvironment. Blood 81:27–34, 1993PubMedGoogle Scholar
  56. 55.
    Bruno E, Hoffman R. Effect of interleukin 6 on in vitro human megakaryocytopoiesis: its interaction with other cytokines. Exp Hematol 17: 1038–1043, 1989PubMedGoogle Scholar
  57. 56.
    Neben TY, Loebelenz J, Hayes L, et al. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood 81:901–908, 1993PubMedGoogle Scholar
  58. 57.
    Herodin F, Mestries JC, Janodet D, et al. Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboons. Blood 80:688–695, 1992PubMedGoogle Scholar
  59. 58.
    Ishibashi T, Miller SL, Burstein SA. Type beta transforming growth factor s a potent inhibitor of murine megakaryocytopoiesis in vitro. Blood 69: 1737–1741, 1987PubMedGoogle Scholar
  60. 59.
    Kuter DJ, Gminski DM, Rosenberg RB. Transformig growth factor-B inhibits megakaryocyte growth and endomitosis. Blood 79:619–626, 1992PubMedGoogle Scholar
  61. 60.
    Gewirtz AM, Calabretta B, Rucinski B, et al. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J Clin Invest 83:1477–1486, 1989PubMedGoogle Scholar
  62. 61.
    Griffin CG, Grant BW: Effects of recombinant interferons on human megakaryocyte growth. Exp Hematol 18:1013–1018, 1990PubMedGoogle Scholar
  63. 62.
    Odell TT Jr, McDonald TP, Detwilder TC. Stimulation of platelet production by serum of platelet-depleted rats. Proc Soc Exp Biol Med 108:428, 1965Google Scholar
  64. 63.
    Spector B. In vivo transfer of a thrombopoietic factor. Proc Soc Exp Biol Med 1961; 108:146PubMedGoogle Scholar
  65. 64.
    Schulman I, Abildgaard CF, Cornet JA, et al. Studies on thrombopoiesis. II. Assay of human plasma thrombopoietic activity. J Pediatr 66:604, 1965PubMedGoogle Scholar
  66. 65.
    Vigon I, Florindo C, Fichelson S, et al. Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth. Oncog 8;2607–2615, 1993Google Scholar
  67. 66.
    Vigon I, Mornon JP, Cocault L, et al. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 89:5640–5644, 1992PubMedGoogle Scholar
  68. 67.
    Methia N, Lauache F, Vainchenker W, Wendling F. Oligodeoxynucleotides antisense to the proto-oncogene C-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 82: 1395–1401, 1993Google Scholar
  69. 68.
    Lok S, Kaushansky K, Holly RD, et al: Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565–568, 1994PubMedGoogle Scholar
  70. 69.
    De Sauvage FJ, Hass PE, Spencer SD, et al: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand, Nature 369:533–538, 1994PubMedGoogle Scholar
  71. 70.
    Kaushansky K, Lok S, Holly RD, et al: Promotion of megakaryocyte progenitor expansion and differentiation by the cMpl ligand thrombopoietin. Nature 369:568–571, 1994PubMedGoogle Scholar
  72. 71.
    Wendling F, Maraskovsky E, Debili N, et al: cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369:571–574, 1994PubMedGoogle Scholar
  73. 72.
    Bartley TD, Bogenberger J, Hunt P, et al: Identification and cloning of megakaryocyte growth and development factor that is a ligand fort he cytokine receptor mpl. Cell 77:1117–1124, 1994PubMedGoogle Scholar
  74. 73.
    Chang MS, NcNinch J, Basu R, et al: Cloning and characterization of the human megakaryocyte growth and development factor (MGDF) gene. J Biol Chem 275:511–514, 1995Google Scholar
  75. 74.
    Foster DC, Sprecher CA, Grant FJ, et al: Human thrombopoietin. Gene structure cDNA sequence, expression, and chromosomal localization. Proc Natl Acad Sci USA 91:13023–13027, 1997Google Scholar
  76. 75.
    Gurney AL, Kuang WJ, Xie MH, et al: Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin. Blood 85:981–988, 1995PubMedGoogle Scholar
  77. 76.
    Deveaux S, Filipe A, Lemarchandel V, et al: Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood 87:4678–4685, 1996PubMedGoogle Scholar
  78. 77.
    Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW. Thrombocytopenia in c-mpl-deficient mice. Science 265:1445–1447, 1994PubMedGoogle Scholar
  79. 78.
    Carver-Moore K, Broxmeyer HE, Luoh SM, et al: Low levels of erythroid and myeloid progenitors in thrombopoietin and c-mpl-deficient mice. Blood 88:803–808, 1996PubMedGoogle Scholar
  80. 79.
    Alxander WS, Roberts AW, Nicola NA, et al. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood 87:2162–2170, 1996Google Scholar
  81. 80.
    de Sauvage FJ, Carver-Moore K, Luoh SM, et al: Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 183:651–656, 1996PubMedGoogle Scholar
  82. 81.
    Fielder PJ, Gurney AL, Stefanich E, et al: Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 87:2154–2161, 1996PubMedGoogle Scholar
  83. 83.
    Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia n the rabbit. Blood 85:2720–2730, 1995PubMedGoogle Scholar
  84. 84.
    Stoffel R, Wiestner A, Skoda RC. Thrombopoietin in thrombocytopenic mice; evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996;87:567–573PubMedGoogle Scholar
  85. 85.
    Boudy VC, Lin NL, Sabath DF, et al. Human Platelets display high-affinity receptors for thrombopoietin. Blood 89:1896–1904, 1997Google Scholar
  86. 86.
    Emmons RV, Reid DM, Cohen RL, et al: Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87:4068–4071, 1996PubMedGoogle Scholar
  87. 87.
    Tahara T, Usuki K, Sato H, et al: A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with hematopoietic disorders. Br J Haematol 93:783–788, 1996PubMedGoogle Scholar
  88. 88.
    Shivdasani RA, Fielder P, Keller GA, et al. Regulation of the serum concentration of thrombopoietin in thrombocytopenic NF-E2 knockout mice. Blood 90:1821–1827, 1997PubMedGoogle Scholar
  89. 89.
    McCarty JM, Sprugel KH, Fox NE, et al. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 86:3668–3675, 1997Google Scholar
  90. 90.
    Sangaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 89:101–107, 1997Google Scholar
  91. 91.
    Zeiger FC, de Sauvage F, Widner HR, et al: In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 84:4045–4952, 1996Google Scholar
  92. 92.
    Young JC, Bruno E. Luens KM, et al. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy- 1+Lin- primitive progenitor cells. Blood 88:1619–1631, 1996PubMedGoogle Scholar
  93. 93.
    Sitnicka E, Lin N, Priestley GV, et al. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood 87:4998–5005, 1996PubMedGoogle Scholar
  94. 94.
    Angchaisuksiri P, Carlson PL, Dessypris EN. Effects of recombinant human thrombopoietin on megakaryocyte colony formation and megakaryocyte ploidy by human CD34+ cells in a serum-free system. Br J Haematol 93:13–17, 1996PubMedGoogle Scholar
  95. 95.
    Kaushansky K, Broudy VC, Grossmann A, et al: Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest 96:1683–1687, 1995PubMedGoogle Scholar
  96. 96.
    Kaushansky K, Broudy VC, Lin N, et al: Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 92:3234–3238, 1992Google Scholar
  97. 97.
    Debili N, Wendling F, Katz A, et al: The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 86:2516–2525,1995PubMedGoogle Scholar
  98. 98.
    Bertolini F, Battaglia M, Pedrazzoli P, et al: Megakaryocyte progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 89:2679–2688, 1997PubMedGoogle Scholar
  99. 99.
    Dolzhansky A, Basch RS, Karpatkin S. The development of human megakaryocytes: III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3. Blood 89:426–434, 1997Google Scholar
  100. 100.
    Wendling F, Maraskovsiy E, Delili N, et al: C-mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369:571–574, 1994PubMedGoogle Scholar
  101. 101.
    Choi ES, Nichol JL, Hokom MM, Hornkohl AC, Hunt P. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 85:402–413, 1995PubMedGoogle Scholar
  102. 102.
    Peng J, Friese P, Wolf RF, et al: Relative reactivity of platelets from thrombopoietin- and interleukin-6-treated dogs. Blood 87:4158–4163, 1997Google Scholar
  103. 103.
    Oda A, Miyakawa Y, Druker BJ, et al: Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood 87:4664–4670,1996PubMedGoogle Scholar
  104. 104.
    Chen J, Herceg-Harjacek L, Gropman JE, Grabarek J. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Blood 86:4054–4062, 1995PubMedGoogle Scholar
  105. 105.
    Yamazaki K, Roberts RA, Sponcer E, et al. Cellular interactions between 3T3 cells and interleukin-3-dependent multipotent haemopoietic cells: a model system for stromal-cell-mediated haemopoiesis. J Cell Physiol 139:301–312,1989PubMedGoogle Scholar
  106. 106.
    Anderson DM, Lyman SD, Baird A, et al: Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63:235–243, 1990PubMedGoogle Scholar
  107. 107.
    Gordon MY, Riley GP, Watt SM, Greaves MF. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 326:403–405, 1987PubMedGoogle Scholar
  108. 108.
    Roberts R, Galagher J, Spooncer E, et al. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 332:376–378, 1988PubMedGoogle Scholar
  109. 109.
    Zucker-Franklin D, Petursson SR. Thrombocytopoiesis: Analysis by membrane tracer and freeze-fracture studies on fresh human and cultured mouse megakaryocytes. J Cell Biochem 99:390–402, 1984Google Scholar
  110. 110.
    Tablin F, Castro M, Levin RM. Blood platelet formation in vitro. The role of the cytoskeleton in megakaryocyte fragmentation. J Cell Sci 97:59–70, 1990PubMedGoogle Scholar
  111. 111.
    Long MW, Dixit VM. Thrombospondin functions as a cytoadhesion molecule for human hematopoietic progenitor cells. Blood 75:2311–2318, 1990PubMedGoogle Scholar
  112. 112.
    Fielder PJ, Hass P, Nagel M, Stefanich E, Widner R, Bennett GL, Keller GA, de Sauvage FJ, Eaton D. Human platelets as a model for the binding and degradation of thrombopoietin. Blood 89:2782–2788, 1997PubMedGoogle Scholar
  113. 113.
    Cohen-Solal K, Villeval JL, Titeux M, et al. Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood 88:2578–2584, 1996PubMedGoogle Scholar
  114. 112.
    Mohle RM, Moore MAS, Nachman RL, Rafii S. Transendothelial migration of CD34+ and mature hematopoietic cells an in vitro study using a human bone marrow endothelial cell line. Blood 89:72–80, 1997PubMedGoogle Scholar
  115. 113.
    Hamada T, Mohle R, Hesselgesser J, et al. Transendothelial migration of megakaryocytes n response to stromal derived factor-1 enhances platelet formation. Blood 90: 360a, 1997.Google Scholar
  116. 114.
    Odel TT, Jackson CD, Friday TJ. Megkaryocytopoiesis in rats with special reference to polyploidy. Blood 335:775–782, 1970Google Scholar
  117. 115.
    Odell TT Jr, Jackson CW. Polyploidy and maturation of rat megakaryocytes. Blood 32:102–110, 1968PubMedGoogle Scholar
  118. 116.
    Odell TT Jr, Jackson CW, Gosslee DG. Maturation of rat megakaryocytes studies by microspectrophotometric measurement of DNA. Proc Soc Exp Biol Med 119:1194–1199, 1965PubMedGoogle Scholar
  119. 117.
    Ebbe S. Biology of megakaryocytes. Prog Hemostasis and Thromb. 3:211–229, 1976Google Scholar
  120. 118.
    De Levai M, Paulus JM. “Megakaryocytes: uninucleate plurinucleate cells?” In Platelet Kinetics, Paulus JM, ed:. Amsterdam, North Holland, 1971Google Scholar
  121. 119.
    Ebbe S, Stohlman F Jr. Megakaryocytopoiesis in the rat. Blood 26:20–35, 1965PubMedGoogle Scholar
  122. 120.
    Feinendegen LE, Odartchenko N, Cottier H, Bond VP. Kinetics of megakaryocyte proliferation. Proc Soc Exp Biol Med 111:177–182, 1962PubMedGoogle Scholar
  123. 121.
    Therman E, Sarto GE, Stubblefield PA. Endomitosis: A reappraisal. Hum Genet 63:13–18, 1983PubMedGoogle Scholar
  124. 122.
    Ebbe S, Stohlman F Jr, Overcash J, Donovan J, Howard DF. Megakaryocyte size in thrombocytopenic and normal rats. Blood 32:383–392, 1968PubMedGoogle Scholar
  125. 123.
    Riabowol K, Draetta G, Brixuela L, et al. The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell 57:393–401, 1989PubMedGoogle Scholar
  126. 124.
    Pines J, Hunter T. Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34-CDC2. Cell 1989;58:833–846PubMedGoogle Scholar
  127. 125.
    Hunter T, Pines. Cyclins and cancer. Cell 66:1071–1074, 1991PubMedGoogle Scholar
  128. 126.
    Matsushime H, Roussel M, Ashmun R, Sherr C. Colony-stimulating factor 1 regulates novel cyclins during the Gl phase of the cell cycle. Cell 65:701–713, 1991PubMedGoogle Scholar
  129. 127.
    Meyerson M, Enders GH, Wu C-L, et al. A family of human cdc2-related protein kinases. EMBO J 11:2909–2917, 1992PubMedGoogle Scholar
  130. 128.
    Ohtsubo M, Theodoras AM, Schumacher J, et al. Human cyclin E, a nuclear protein essential for the Gl-to-S phase transition. Mol Cell Biol 15:2612–2624, 1995PubMedGoogle Scholar
  131. 129.
    Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. Cyclin A is required at two points n the human cell cycle. EMBO J 11:961–971, 1992PubMedGoogle Scholar
  132. 130.
    Dou QP, levin AH, Zhao S, Pardee AB. Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res 53:1493–1497, 1993Google Scholar
  133. 131.
    Dulic V, Lees E, Reed SI. Association of human cyclin E with a periodic Gl-S phase protein kinase. Science 257:1958–1961, 1992PubMedGoogle Scholar
  134. 132.
    Girard F, Strausfeld U, Fernandez A, Lamb NJ. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 676:1169–1179, 1992Google Scholar
  135. 133.
    KorT A, Griordino A, Desai D, et al. Formulation and activation of a cyclin E-cdk2 complex during Gl phase of the human cell cycle. Science 257:1689–1694, 1992Google Scholar
  136. 134.
    Matshushime H, Ewen ME, Strom DK, et al. Identification and properties of an atypical catalytic subunit (p34 psk-j3/cdk4) for mammalian D type Gl cyclins. Cell 71:323–334, 1992Google Scholar
  137. 135.
    Hunter T, Pines J. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79:573–582, 1994PubMedGoogle Scholar
  138. 136.
    Xiong Y, Zhang H, Beach D. D type cyclin associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505–514, 1992PubMedGoogle Scholar
  139. 137.
    Draetta G, Beach D. Activation of cdc2 protein kinase during mitosis in human cells: cell-cycle-dependent phosphorylation and subunit rearrangement. Cell 54:17–26, 1988PubMedGoogle Scholar
  140. 138.
    Luca FC, Shibuya ED, Dohrmann CE, Ruderman JV. Both Cyclin A delta 60 and B delta 97 are stable and arrest cells in M-phase, but only cyclin B delta 97 turns on cyclin destruction. EMBO J 10:4311–4320, 1991PubMedGoogle Scholar
  141. 138.
    Gallant P, Nigg EA. Cyclin B2 undergoes cell cycle-dependent nuclear translocation and, when expressed as a non-destructible mutant, causes mitotic arrest in HeLa cells. J Cell Biochem 117:213–224, 1992Google Scholar
  142. 140.
    Long MW, Heffner CH, Williams JL, Peters C, Prochownik EV. Regulation of megakaryocyte potential in human erythroleukemia cells. J. Clin Invest 85:1072–1084, 1990PubMedGoogle Scholar
  143. 141.
    Datta N, Williams JL, Long MW. Alterations in cyclin-dependent kinase complex formation during the acquisition of polyploid DNA content. Mol Biol Cell 7:209–223, 1996PubMedGoogle Scholar
  144. 142.
    Zhang Y, Wang Z, Ravid K. The cell cycle in polyploid megakaryocytes is associated with reduced activity of cyclin B1-dependent cdc2 kinase. J Biol Chem 271:4266–4266, 1996PubMedGoogle Scholar
  145. 143.
    Datta NS, Long MW. The role of cyclin D3- and cyclin E- cell division kinase complexes in megakaryocyte endomitosis. Blood (abstr);82:209, 1993Google Scholar
  146. 144.
    Wang Z, Zhang Y, Kamen D, Lees E, Ravid K. Cyclin D3 is essential for megakaryocytopoiesis, Blood 865:3783–3788, 1995Google Scholar
  147. 145.
    Long MW, Hoffman R. “Megakaryocytopoiesis.” In Hematology Basic Principles and Practice, R. Hoffinan, EJ Benz Jr, HJ Cohen, P McGlave, L Silberstein, B Furie, S Shattil, eds. New York, NY: WB Saunders, (In press), 1999Google Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Ronald Hoffman
  • Michael W. Long

There are no affiliations available

Personalised recommendations